HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION
US Application 19/334,152
Filed on 2025-09-19
Filed on 2025-09-19
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
European Patent
25206361.5
Filed on 2025-10-02
25206361.5
Filed on 2025-10-02
ENGINEERED RNA DEVICES IN HUMAN T-CELLS TO CONTROL GENE EXPRESSION EXTERNALLY
Patent Cooperation Treaty
PCT/US2025/042148
Filed on 2025-08-15
PCT/US2025/042148
Filed on 2025-08-15
METHODS FOR ENHANCING THE IMMUNOGENICITY OF CELLULAR VACCINES
Patent Cooperation Treaty
PCT/US2024/022230
Filed on 2024-03-29
PCT/US2024/022230
Filed on 2024-03-29
Peptide-pulsed MHC class II semi-allogeneic dendritic cell vaccine induces more efficacious anti-tumor responses
US Application 63/456,176
Filed on 2023-03-31
Filed on 2023-03-31
AUTOPHAGY MODULATORS AND METHODS OF USE
Patent Cooperation Treaty
PCT/US2025/051307
Filed on 2025-10-16
PCT/US2025/051307
Filed on 2025-10-16
AUTOPHAGY MODULATORS AND METHODS OF USE
US Application 63/707,961
Filed on 2024-10-16
Filed on 2024-10-16
AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION
Patent Cooperation Treaty
PCT/US2025/050250
Filed on 2025-10-09
PCT/US2025/050250
Filed on 2025-10-09
AUTOPHAGY INHIBITOR THAT TARGETS THE ATG14L-BECLIN1 PROTEIN-PROTEIN INTERACTION
US Application 63/705,241
Filed on 2024-10-09
Filed on 2024-10-09
T CELL RECEPTORS TARGETING Y220C OR R175H MUTATION IN P53
European Patent
24721308.5
Filed on 2025-10-21
24721308.5
Filed on 2025-10-21